使用血液学指数来预测DTC患者肝功能受损的情况
1Department of Nuclear Medicine, Jinshan Hospital of Fudan University, Shanghai, China. chaihongggg@126.com.
Hellenic journal of nuclear medicine
|April 17, 2024
概括
甲状腺疾病会导致肝脏功能障碍. 这项研究发现,血小板计数和绝对淋巴细胞计数可以预测利沃西撤销后差异化甲状腺癌患者的肝损伤.
科学领域:
- 内分泌学 在内分泌学.
- 肝病学 肝病学是一种肝病学.
- 血液学 血液学 血液学
背景情况:
- 甲状腺疾病,特别是甲状腺功能低下症,与肝损伤有关.
- 甲状腺疾病引起的肝功能障碍的机制需要进一步阐明.
- 差异化甲状腺癌 (DTC) 患者因放射性分离而接受甲状腺素 (LT4) 禁用,该过程可能会影响肝功能.
研究的目的:
- 评估DTC患者在LT4停用前和之后的血液功能趋势.
- 为了确定经过LT4撤销的DTC患者肝损伤的预测因素.
- 探索血液学指数与甲状腺功能低下相关的肝损伤之间的关系.
主要方法:
- 对157名DTC患者进行了回顾性研究.
- 在基线和LT4停药后4周内血液学参数的分析.
- 后勤回归分析以确定肝损伤的重要预测因素.
主要成果:
- 在LT4停用4周后,64名患者 (40.8%) 发生肝损伤.
- 单变分析确定了血小板计数 (PC),平均血小板体积 (MPV),血小板分布宽度 (PDW) 和绝对淋巴细胞计数 (ALC) 作为危险因素.
- 多变量分析显示,增加PC和减少ALC是肝损伤的独立预测因素.
结论:
- 血小板计数和绝对淋巴细胞计数是甲状腺功能低下症相关肝损伤的独立预测指标.
- 这项研究首次表明了血液学指数在预测与甲状腺功能低下相关的肝脏疾病中的有用性.
- 血液学标记可能有助于早期检测和管理DTC患者的肝功能障碍.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
386
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
386
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
275
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
275
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
1.2K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K


